Citations (15)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (5)
Sujatro Chakladar, Ran Liao & Margaret Gamalo. (2023) Estimands, Handling of Missing Data and Impact on Assumed Effect Size and Power in Pivotal COVID-19 Treatment Trials. Journal of Biopharmaceutical Statistics 33:4, pages 403-424.
Read now
Read now
Jessica K. Roydhouse, Lysbeth Floden, Rachel L. Tomko, Kevin M. Gray & Melanie L. Bell. (2021) The estimand framework and its application in substance use disorder clinical trials: a case study. The American Journal of Drug and Alcohol Abuse 47:6, pages 658-663.
Read now
Read now
Lorenzo Guizzaro, Frank Pétavy, Robin Ristl & Ciro Gallo. (2021) The Use of a Variable Representing Compliance Improves Accuracy of Estimation of the Effect of Treatment Allocation Regardless of Discontinuation in Trials with Incomplete Follow-up. Statistics in Biopharmaceutical Research 13:1, pages 119-127.
Read now
Read now
Elena Polverejan & Vladimir Dragalin. (2020) Aligning Treatment Policy Estimands and Estimators—A Simulation Study in Alzheimer’s Disease. Statistics in Biopharmaceutical Research 12:2, pages 142-154.
Read now
Read now
Klaus Groes Larsen & Mette Krog Josiassen. (2020) A New Principal Stratum Estimand Investigating the Treatment Effect in Patients Who Would Comply, If Treated With a Specific Treatment. Statistics in Biopharmaceutical Research 12:1, pages 29-38.
Read now
Read now
Articles from other publishers (10)
Alex Ocampo & Jemar R. Bather. (2023) Single‐world intervention graphs for defining, identifying, and communicating estimands in clinical trials. Statistics in Medicine 42:21, pages 3892-3902.
Crossref
Crossref
R. Bissonnette, L. F. Eichenfield, E. Simpson, D. Thaçi, K. Kabashima, J. P. Thyssen, E. Guttman‐Yassky, F. P. Nunes, M. Gamalo, F. Ahmad, M. Kuligowski, K. Sun, C. Pipper, A. W. Christensen, P. D'Angelo, M. Milutinovic, A. Guettner & J. I. Silverberg. (2023) Estimands for atopic dermatitis clinical trials: Expert opinion on the importance of intercurrent events. Journal of the European Academy of Dermatology and Venereology 37:5, pages 976-983.
Crossref
Crossref
Eivind Hasvik, Jon Michael Gran, Anne Julsrud Haugen & Lars Grøvle. (2022) Strategies to manage auxiliary pain medications in chronic pain trials: a topical review. European Journal of Clinical Pharmacology 78:9, pages 1377-1384.
Crossref
Crossref
Bethea A. Kleykamp, Robert H. Dworkin, Dennis C. Turk, Zubin Bhagwagar, Penney Cowan, Christopher Eccleston, Susan S. Ellenberg, Scott R. Evans, John T. Farrar, Roy L. Freeman, Louis P. Garrison, Jennifer S. Gewandter, Veeraindar Goli, Smriti Iyengar, Alejandro R. Jadad, Mark P. Jensen, Roderick Junor, Nathaniel P. Katz, J. Patrick Kesslak, Ernest A. Kopecky, Dmitri Lissin, John D. Markman, Michael P. McDermott, Philip J. Mease, Alec B. O'Connor, Kushang V. Patel, Srinivasa N. Raja, Michael C. Rowbotham, Cristina Sampaio, Jasvinder A. Singh, Ilona Steigerwald, Vibeke Strand, Leslie A. Tive, Jeffrey Tobias, Ajay D. Wasan & Hilary D. Wilson. (2022) Benefit–risk assessment and reporting in clinical trials of chronic pain treatments: IMMPACT recommendations. Pain 163:6, pages 1006-1018.
Crossref
Crossref
Anneke C. Grobler, Katherine J. Lee, Aaron Wong, David C. Currow & Sabine Braat. (2022) Handling Missing Data and Drop Out in Hospice/Palliative Care Trials Through the Estimand Framework. Journal of Pain and Symptom Management 63:4, pages e431-e439.
Crossref
Crossref
Andrew S.C. Rice, Robert H. Dworkin, Nanna B. Finnerup, Nadine Attal, Praveen Anand, Roy Freeman, Alessandro Piaia, Francesca Callegari, Christie Doerr, Subhayan Mondal, Nisha Narayanan, Laurent Ecochard, Yanina Flossbach & Shaloo Pandhi. (2021) Efficacy and safety of EMA401 in peripheral neuropathic pain: results of 2 randomised, double-blind, phase 2 studies in patients with postherpetic neuralgia and painful diabetic neuropathy. Pain 162:10, pages 2578-2589.
Crossref
Crossref
Robert H. Dworkin, Scott R. Evans, Omar Mbowe & Michael P. McDermott. (2021) Essential statistical principles of clinical trials of pain treatments. PAIN Reports 6:1, pages e863.
Crossref
Crossref
Rachael Lawrance, Evgeny Degtyarev, Philip Griffiths, Peter Trask, Helen Lau, Denise D’Alessio, Ingolf Griebsch, Gudrun Wallenstein, Kim Cocks & Kaspar Rufibach. (2020) What is an estimand & how does it relate to quantifying the effect of treatment on patient-reported quality of life outcomes in clinical trials?. Journal of Patient-Reported Outcomes 4:1.
Crossref
Crossref
Shannon M. Smith, Maurizio Fava, Mark P. Jensen, Omar B. Mbowe, Michael P. McDermott, Dennis C. Turk & Robert H. Dworkin. (2020) John D. Loeser Award Lecture: Size does matter, but it isn't everything: the challenge of modest treatment effects in chronic pain clinical trials. Pain 161:Supplement 1, pages S3-S13.
Crossref
Crossref
Man Jin & Guanghan Liu. (2020) Estimand framework: Delineating what to be estimated with clinical questions of interest in clinical trials. Contemporary Clinical Trials 96, pages 106093.
Crossref
Crossref